02.28.14
The Medical Technology Association of Australia (MTAA) has named Gary Burgess its new director of regulatory affairs, a post he will assume on March 17 this year.
“I’m delighted to announce Gary’s appointment,” said Susi Tegan, chief executive of the MTAA, just appointed in October last year. “With his background in biomedical engineering and years of experience working at the Therapeutic Goods Association (TGA), he will provide valuable leadership and services to the medical technology industry and MTAA.”
Tegan went on to say that Burgess’ knowledge of the medtech industry runs deep, stemming from previous positions held with the TGA. He presented a training module for the MTAA over a number of years and participated in various industry meetings.
“Gary will be a valuable addition to MTAA, steering the industry through the implementation of a range of regulator reforms including the up-classification of orthopedic joint implants, the introduction of third party conformity assessment in Australia and the continued work on harmonizing global regulatory systems,” Tegan concluded.
Burgess brings with him experience from both private and public health sectors covering technical knowledge of medical devices, an understanding of global regulatory frameworks, knowledge of Australian and European legislation, and experience in the assessment of high risk medical devices and quality management system audits.
“I’m looking forward to starting my new role at MTAA and meeting with members,” Burgess said. “My knowledge of medical technologies combined with my knowledge of the Australian and global regulatory processes will enable me to provide leadership and guidance to MTAA members.”
Burgess’ last position at the TGA was section director in the Office of Device Authorisation, where he was responsible for processing medical device applications for entry on the Australian Register of Therapeutic Goods (ARTG) and for assessing applications from medical device manufacturers for Conformity Assessment certificates.
MTAA is the national association representing companies in the medical technology industry.
“I’m delighted to announce Gary’s appointment,” said Susi Tegan, chief executive of the MTAA, just appointed in October last year. “With his background in biomedical engineering and years of experience working at the Therapeutic Goods Association (TGA), he will provide valuable leadership and services to the medical technology industry and MTAA.”
Tegan went on to say that Burgess’ knowledge of the medtech industry runs deep, stemming from previous positions held with the TGA. He presented a training module for the MTAA over a number of years and participated in various industry meetings.
“Gary will be a valuable addition to MTAA, steering the industry through the implementation of a range of regulator reforms including the up-classification of orthopedic joint implants, the introduction of third party conformity assessment in Australia and the continued work on harmonizing global regulatory systems,” Tegan concluded.
Burgess brings with him experience from both private and public health sectors covering technical knowledge of medical devices, an understanding of global regulatory frameworks, knowledge of Australian and European legislation, and experience in the assessment of high risk medical devices and quality management system audits.
“I’m looking forward to starting my new role at MTAA and meeting with members,” Burgess said. “My knowledge of medical technologies combined with my knowledge of the Australian and global regulatory processes will enable me to provide leadership and guidance to MTAA members.”
Burgess’ last position at the TGA was section director in the Office of Device Authorisation, where he was responsible for processing medical device applications for entry on the Australian Register of Therapeutic Goods (ARTG) and for assessing applications from medical device manufacturers for Conformity Assessment certificates.
MTAA is the national association representing companies in the medical technology industry.